H J Adrogué1, N E Madias. 1. Department of Medicine, Baylor College of Medicine, Department of Veterans' Affairs Medical Center, Houston, Texas, USA.
Abstract
OBJECTIVE: The goal of the present study was to develop a novel approach that facilitates the prescription of fluid therapy in patients with abnormal serum sodium concentration. METHODOLOGY AND RESULTS: The novel approach is based on a simple equation, derived from established principles on the distribution of sodium in body fluids, that estimates the impact of a unit dose, i.e., 1 l of any infusate on the patient's serum sodium concentration. In accordance with the equation, the expected change in the patient's serum sodium concentration in response to 1 l of any infusate (delta[Na+]s) is obtained by subtracting the sodium concentration of the patient's serum from the sodium concentration of the infusate, each expressed in mEq/l, and dividing the result by the patient's estimated total body water expressed in liters (adding 1 l to account for the volume of the infusate). The amount of the particular infusate to be administered over the course of any given time period can be easily computed by dividing the desired delta[Na+]s at the end of the period by the calculated delta[Na+]s effected by 1 l of the infusate. The utility and limitations of the proposed approach are presented. CONCLUSIONS: The novel equation is not a means for formulating therapy. Rather, it provides, simply and expeditiously, quantitative projections that can assist the physician in implementing the selected treatment plan for patients with dysnatremias.
OBJECTIVE: The goal of the present study was to develop a novel approach that facilitates the prescription of fluid therapy in patients with abnormal serum sodium concentration. METHODOLOGY AND RESULTS: The novel approach is based on a simple equation, derived from established principles on the distribution of sodium in body fluids, that estimates the impact of a unit dose, i.e., 1 l of any infusate on the patient's serum sodium concentration. In accordance with the equation, the expected change in the patient's serum sodium concentration in response to 1 l of any infusate (delta[Na+]s) is obtained by subtracting the sodium concentration of the patient's serum from the sodium concentration of the infusate, each expressed in mEq/l, and dividing the result by the patient's estimated total body water expressed in liters (adding 1 l to account for the volume of the infusate). The amount of the particular infusate to be administered over the course of any given time period can be easily computed by dividing the desired delta[Na+]s at the end of the period by the calculated delta[Na+]s effected by 1 l of the infusate. The utility and limitations of the proposed approach are presented. CONCLUSIONS: The novel equation is not a means for formulating therapy. Rather, it provides, simply and expeditiously, quantitative projections that can assist the physician in implementing the selected treatment plan for patients with dysnatremias.
Authors: Bruno Adler Maccagnan Pinheiro Besen; André Luiz Nunes Gobatto; Lívia Maria Garcia Melro; Alexandre Toledo Maciel; Marcelo Park Journal: World J Crit Care Med Date: 2015-05-04
Authors: Muhammad R Toor; Anjali Singla; Maria V DeVita; Jordan L Rosenstock; Michael F Michelis Journal: Int Urol Nephrol Date: 2014-05-10 Impact factor: 2.370
Authors: Christos Argyropoulos; Helbert Rondon-Berrios; Dominic S Raj; Deepak Malhotra; Emmanuel I Agaba; Mark Rohrscheib; Zeid Khitan; Glen H Murata; Joseph I Shapiro; Antonios H Tzamaloukas Journal: Cureus Date: 2016-05-02
Authors: Rosa D Wouda; Rik H G Olde Engberink; Eliane F E Wenstedt; Jetta J Oppelaar; Liffert Vogt Journal: Nephron Date: 2021-06-18 Impact factor: 2.847
Authors: Antoine Roquilly; Pierre Joachim Mahe; Dominique Demeure Dit Latte; Olivier Loutrel; Philippe Champin; Christelle Di Falco; Athanase Courbe; Kevin Buffenoir; Olivier Hamel; Corinne Lejus; Véronique Sebille; Karim Asehnoune Journal: Crit Care Date: 2011-10-28 Impact factor: 9.097